Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
ZLDPF:OTCMKTS
Zealand Pharma A/S
USD 47,37
-0,98%
(-0,47) 1D
1 Mei, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZLDPF...
Open
USD 49,75
High
USD 49,75
Low
USD 47,37
Mkt. cap
3,47 mjd
Avg. vol.
1,18 k
Volume
2,32 k
52-wk high
USD 83,12
52-wk low
USD 35,93
Beta
1,29
Shares outstanding
71,53 m
No. of employees
491
News stories
From sources across the web
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S
CEOAdam Steensberg
Employees491
Founded01 Apr. 1997
Headquarters-
Sector-
Websitezealandpharma.com
Previous reportsAll values in DKK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in DKK
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
8,09 m
9,09 mjd
49,57 m
68,92 m
Cost of goods sold
405,00 k
410,00 k
-
-
Cost of revenue
405,00 k
410,00 k
-
-
Research and development expenses
290,32 m
464,14 m
320,04 m
530,07 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
102,83 m
110,46 m
190,85 m
91,81 m
Operating expense
414,72 m
749,45 m
510,89 m
621,88 m
Total operating expenses
415,13 m
749,86 m
510,89 m
621,88 m
Operating income
-407,04 m
8,34 mjd
-461,32 m
-552,97 m
Other non operating income
30,56 m
2,98 m
-17,59 m
-7,23 m
EBT including unusual items
-336,72 m
8,11 mjd
-366,73 m
-406,51 m
EBT excluding unusual items
-354,46 m
8,11 mjd
-383,62 m
-460,20 m
Income tax expense
-1,38 m
537,32 m
37,50 m
-27,39 m
Effective tax rate
0,41%
6,62%
-10,23%
6,74%
Other operating expenses
21,58 m
174,85 m
-
1,00 k
Net income
-335,34 m
7,57 mjd
-404,23 m
-379,12 m
Net profit margin
-4 144,13%
83,33%
-815,50%
-550,12%
Earnings per share
-4,75
105,61
-5,75
-5,19
Interest and investment income
41,62 m
56,36 m
108,95 m
102,41 m
Interest expense
-7,65 m
-7,34 m
-7,00 m
-7,07 m
Net interest expenses
33,97 m
49,02 m
101,95 m
95,34 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-401,08 m
8,34 mjd
-454,10 m
-550,48 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer